GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akari Therapeutics PLC (FRA:CLA) » Definitions » Non Operating Income

Akari Therapeutics (FRA:CLA) Non Operating Income : €-1.69 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Akari Therapeutics Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Akari Therapeutics's Non Operating Income for the three months ended in Dec. 2024 was €0.62 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was €-1.69 Mil.

Akari Therapeutics Non Operating Income Historical Data

The historical data trend for Akari Therapeutics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akari Therapeutics Non Operating Income Chart

Akari Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 -0.20 5.00 6.16 -2.78

Akari Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.39 -1.82 -0.88 0.62

Akari Therapeutics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akari Therapeutics Non Operating Income Related Terms

Thank you for viewing the detailed overview of Akari Therapeutics's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Akari Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akari Therapeutics PLC (FRA:CLA) » Definitions » Non Operating Income
Comparable Companies
CAMP ATNM BLUE RNTX SPRO PVCT RVPH HOWL ATRA XLO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
AKTX:USA
Address
22 Boston Wharf Road, Boston, MA, USA, 02210
Website
https://www.akaritx.com
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).